People with an allergy or severe sensitivity to peanuts "may risk serious or life-threatening allergic reactions by consuming ...

On Nov. 26, 2019, ChemoCentryx issued a press release announcing that the Advocate trial met both of its primary endpoints, saying Tavneos showed noninferiority of disease remission at 26 weeks and ...

Verastem Oncology's VS-7375 receives FDA fast track designation, offering hope for targeted treatment in KRAS G12D-mutated ...

A popular coffee brand has issued a voluntary recall of its single-serve coffee pods. The FDA published the recall notice for New Mexico Piñon Coffee over concerns that ink from the lids may run into ...

Mike Pence's think tank is asking the Food and Drug Administration to turn over documents related to the dangers of the ...

Apoquel Chewable is an FDA-approved chewable treatment in the U.S. prescribed to control itching associated with allergic ...

Morning. Today, we discuss how Duchenne patients and their families are responding to the shelving of Sarepta Therapeutics’ ...

From softwares to implants, here are 10 spine products earning FDA nods since May 15. 1. Accelus’ FlareHawk interbody fusion device was FDA-cleared for use in MRI scanning under certain conditions.

Moderna has scrapped plans to build an mRNA plant in Japan. Otsuka and Lundbeck's proposal for Rexulti as part of a PTSD ...

U.S. Food and Drug Administration Commissioner Marty Makary said he is focused on overhauling long-held standards and ...

There was a lot of excitement when Tepezza became the first drug approved for the treatment of thyroid eye disease in January ...

The strategic reprioritization comes after the company hit two major hurdles in the past year, including a clinical hold for ...